These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7331843)

  • 41. [Choreic syndrome following intramuscular exhibition of a contraceptive preparation (author's transl)].
    Knoblich OE; Witt TN; Meyendorf R; Spatz R
    Nervenarzt; 1981 Apr; 52(4):239-42. PubMed ID: 6453300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
    Arana GW; Goff DC; Friedman H; Ornsteen M; Greenblatt DJ; Black B; Shader RI
    Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Controlled comparison of nalorphine with haloperidol in acute psychoses of the schizophrenic group ].
    Svestka J; Náhunek K; Cesková E; Rysánek R
    Cesk Psychiatr; 1982 Jun; 78(3):159-66. PubMed ID: 6749311
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapeutic action of IB-503 evaluated on the strength of the author's 4-year clinical experience].
    Bilikiewicz A; Zurada-Wyrwińska J
    Psychiatr Pol; 1971; 5(5):577-84. PubMed ID: 5156543
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam.
    Currier GW; Chou JC; Feifel D; Bossie CA; Turkoz I; Mahmoud RA; Gharabawi GM
    J Clin Psychiatry; 2004 Mar; 65(3):386-94. PubMed ID: 15096079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outpatient titration with intramuscular haloperidol as an alternative to psychiatric hospitalization.
    Ingall MA; Farber BL; Kuppe JV; Silveira AP
    R I Med J (1976); 1979 Nov; 62(11):437-42. PubMed ID: 293841
    [No Abstract]   [Full Text] [Related]  

  • 48. Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection. Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol.
    Aravagiri M; Marder SR; Van Putten T; Marshall BD
    J Chromatogr B Biomed Appl; 1994 Jun; 656(2):373-81. PubMed ID: 7987490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bromperidol decanoate in the residual phase of schizophrenia].
    Smeraldi E; Cocconcelli C; Canova L; Faravelli C; Marchetti FP; Mariani G; Rapisarda V
    Minerva Psichiatr; 1996 Mar; 37(1):39-44. PubMed ID: 8926856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haloperidol decanoate in children.
    Alessi N; Alkhouri I; Fluent T; Quinlan P; Williams K
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):865-6. PubMed ID: 11501680
    [No Abstract]   [Full Text] [Related]  

  • 51. [Ambulatory treatment of psychoses. Report from a discussion meeting].
    Robak OH
    Tidsskr Nor Laegeforen; 1976 Aug; 96(24):1285-6. PubMed ID: 968863
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experience in the management of chronic psychoses using fluphenazine-oenanthate].
    Eichstetter F
    Nervenarzt; 1968 Jun; 39(6):282-3. PubMed ID: 5712435
    [No Abstract]   [Full Text] [Related]  

  • 53. Psychotropic prescribing for acute inpatient admissions in patients with severe psychosis.
    Lambert T; Kelly DL; Alcock S; Conley RR
    J Clin Psychopharmacol; 2004 Feb; 24(1):91-3. PubMed ID: 14709954
    [No Abstract]   [Full Text] [Related]  

  • 54. Single-dose pharmacokinetics of fluphenazine after fluphenazine decanoate administration.
    Simpson GM; Yadalam KG; Levinson DF; Stephanos MJ; Lo ES; Cooper TB
    J Clin Psychopharmacol; 1990 Dec; 10(6):417-21. PubMed ID: 2286711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
    Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blood levels of haloperidol and clinical outcome in schizophrenia.
    Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M
    J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Violent and self-injurious behaviour in mentally handicapped patients--psychopharmacological control.
    Read SG; Batchelor DH
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():63-74. PubMed ID: 3559162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
    Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
    Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Haloperidol in the treatment of psychotic disorders in old age].
    Kobrzyńska E; Chachaj L
    Psychiatr Pol; 1982; 16(1-2):13-7. PubMed ID: 7146202
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.